Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

CVS, Walgreens and Walmart ordered to pay $650M for role in opioid epidemic

Three major pharmacy names will have to fork over hundreds of millions of dollars to two Ohio counties for their roles in the opioid epidemic, a judge has ruled.

PET imaging uncovers a surprising new way COVID-19 affects the heart

A new study in JACC: Cardiovascular Imaging focuses on a potential new side effect of COVID-19, highlighting the continued importance of monitoring these patients going forward. 

Thumbnail

TAVR programs follow inconsistent DNR policies, potentially skewing data

Not all hospitals respect the written preferences of patients, possibly motivated by a desire to report better TAVR outcomes.

coronavirus COVID-19 vaccine vaccination

CDC director slams agency's response to COVID-19 pandemic

“For 75 years, CDC and public health have been preparing for Covid-19, and in our big moment, our performance did not reliably meet expectations,” said Rochelle P. Walensky, MD, MPH, director of the Centers for Disease Control and Prevention.

American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification

The new certification, based on recommendations published in Circulation, was developed to signal that a facility offers cardiac surgery and primary PCI at all times. 

‘Nicotine delivery systems’ impede child brain growth, and the effect is observable in behavioral medicine

Children who begin using tobacco at 9 to 10 years old have significantly smaller brain area and volume than non-users within two years, according to a study published this month. 

Thumbnail

Moderate aortic stenosis linked to a significant risk of death—should earlier interventions be considered?

Researchers tracked data from more than 12,000 moderate AS patients who originally participated in one of 25 different studies. While the findings seem to suggest earlier treatment could be beneficial for certain high-risk patients, additional research is still required.

Thumbnail

Boston Scientific acquires startup behind new FDA-cleared embolization technology

The new hydrogel material was designed to immediately conform to the patient's body and create a barrier.